Видео ютуба по тегу Biohaven Pharmaceuticals

Biohaven Pharmaceuticals CEO on how Nurtec migraine drug punches above its weight
Biohaven Pharmaceuticals CEO on how Nurtec migraine drug punches above its weight
Biohaven (BHVN) Stock Analysis: Is It A Buy, Sell, or Hold?
Biohaven (BHVN) Stock Analysis: Is It A Buy, Sell, or Hold?
Biohaven Pharmaceutical CEO on efforts to prevent migraines with oral CGRP
Biohaven Pharmaceutical CEO on efforts to prevent migraines with oral CGRP
Biohaven Pharmaceuticals (NYSE: BHVN) Rings The Opening Bell®
Biohaven Pharmaceuticals (NYSE: BHVN) Rings The Opening Bell®
What is it like to have OCD? Biohaven Pharmaceuticals
What is it like to have OCD? Biohaven Pharmaceuticals
BHVN Biohaven: 3 Price Scenarios After FDA CRL & Nov 11 Offering - Price Forecast 🚨
BHVN Biohaven: 3 Price Scenarios After FDA CRL & Nov 11 Offering - Price Forecast 🚨
Biohaven Pharmaceuticals shares surge after Pfizer agrees to acquire company
Biohaven Pharmaceuticals shares surge after Pfizer agrees to acquire company
BIOHAVEN PHARMACEUTICALS (NYSE: BHVN) RINGS THE OPENING BELL®
BIOHAVEN PHARMACEUTICALS (NYSE: BHVN) RINGS THE OPENING BELL®
Biohaven Pharma CEO: We're looking to end 30-year drought in new migraine prevention drugs
Biohaven Pharma CEO: We're looking to end 30-year drought in new migraine prevention drugs
Biohaven’s OCD Clinical Trial Featured on WCVB NewsCenter 5 in Boston
Biohaven’s OCD Clinical Trial Featured on WCVB NewsCenter 5 in Boston
OCD Research Study - Biohaven Pharmaceuticals
OCD Research Study - Biohaven Pharmaceuticals
Pfizer acquires Biohaven Pharmaceutical, is this the biggest for the sector?
Pfizer acquires Biohaven Pharmaceutical, is this the biggest for the sector?
Edith's Story of MSA.
Edith's Story of MSA.
Welcome to UConn, Vlad Coric MD, CEO of Biohaven
Welcome to UConn, Vlad Coric MD, CEO of Biohaven
OCD Research - Biohaven Pharmaceuticals
OCD Research - Biohaven Pharmaceuticals
Biohaven CEO on teaming with Khloé Kardashian on new migraine campaign
Biohaven CEO on teaming with Khloé Kardashian on new migraine campaign
Анализ акций BHVN Biohaven: После неудачного пробного запуска — 5 ключевых движений + прогнозируе...
Анализ акций BHVN Biohaven: После неудачного пробного запуска — 5 ключевых движений + прогнозируе...
Pfizer acquires Biohaven for $11.6 billion in cash
Pfizer acquires Biohaven for $11.6 billion in cash
Cure SMA and Biohaven Pharmaceuticals Clinical Trial Update Webinar
Cure SMA and Biohaven Pharmaceuticals Clinical Trial Update Webinar
Новое клиническое исследование спиноцеребеллярной атаксии
Новое клиническое исследование спиноцеребеллярной атаксии